Sales revenues for July 2025

Sofia, Bulgaria, August 20, 2025 – According to the requirements of Art. 100t of the Law on Public Offering of Securities (LPOS), “Sopharma” AD (SFA: “Bulgarian Stock Exchange” AD, SPH: Warsaw Stock Exchange) notifies, that for July 2025 the Company recorded decrease in sales of 23% compared to the same month of the previous year, incl. 25% decrease in domestic sales and 22% decrease in export sales.

For the period from the beginning of 2025, the Company realized a 4% increase in sales, including 6% decrease in domestic sales and a 12% increase in export sales.